Name | methyl 2-piperazin-1-yl-1,3-thiazole-5-carboxylate |
---|---|
Synonyms |
5-Thiazolecarboxylic acid, 2-(1-piperazinyl)-, methyl ester
2-Piperazin-1-yl-thiazole-5-carboxylic acid methyl ester Methyl 2-(1-piperazinyl)-1,3-thiazole-5-carboxylate |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 366.9±52.0 °C at 760 mmHg |
Molecular Formula | C9H13N3O2S |
Molecular Weight | 227.283 |
Flash Point | 175.7±30.7 °C |
Exact Mass | 227.072845 |
PSA | 82.70000 |
LogP | -0.22 |
Vapour Pressure | 0.0±0.8 mmHg at 25°C |
Index of Refraction | 1.565 |
Storage condition | 2-8°C |
HS Code | 2934100090 |
---|
~% 726185-68-8 |
Literature: Miikana Therapeutics Corporation Patent: US2005/197336 A1, 2005 ; Location in patent: Page/Page column 30-31 ; |
~33% 726185-68-8 |
Literature: Boehringer Ingelheim International GmbH Patent: US2004/192729 A1, 2004 ; Location in patent: Page 34 ; |
Precursor 3 | |
---|---|
DownStream 0 |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |